Fresenius Medical Care AG KGaA Return on Investment 2012-2025 | FMS
Current and historical return on investment (ROI) values for Fresenius Medical Care AG KGaA (FMS) over the last 10 years.
| Fresenius Medical Care AG KGaA ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-09-30 | $1.66B | $23.65B | 7.09% |
| 2025-06-30 | $1.61B | $23.45B | 6.93% |
| 2025-03-31 | $1.59B | $22.81B | 6.79% |
| 2024-12-31 | $1.51B | $23.84B | 6.36% |
| 2024-09-30 | $1.69B | $23.12B | 7.17% |
| 2024-06-30 | $1.54B | $23.74B | 6.40% |
| 2024-03-31 | $1.47B | $24.05B | 6.11% |
| 2023-12-31 | $1.48B | $23.58B | 6.15% |
| 2023-09-30 | $1.39B | $24.71B | 5.74% |
| 2023-06-30 | $1.51B | $23.91B | 6.23% |
| 2023-03-31 | $1.48B | $24.21B | 6.10% |
| 2022-12-31 | $1.59B | $23.83B | 6.52% |
| 2022-09-30 | $1.74B | $24.98B | 7.08% |
| 2022-06-30 | $1.86B | $24.17B | 7.68% |
| 2022-03-31 | $2.01B | $24.68B | 8.37% |
| 2021-12-31 | $2.19B | $24.40B | 9.24% |
| 2021-09-30 | $2.24B | $23.60B | 9.70% |
| 2021-06-30 | $2.38B | $23.27B | 10.40% |
| 2021-03-31 | $2.59B | $23.53B | 11.53% |
| 2020-12-31 | $2.63B | $21.85B | 12.04% |
| 2020-09-30 | $2.76B | $22.95B | 12.59% |
| 2020-06-30 | $2.68B | $21.58B | 12.40% |
| 2020-03-31 | $2.55B | $21.04B | 12.18% |
| 2019-12-31 | $2.54B | $22.05B | 12.10% |
| 2019-09-30 | $2.55B | $21.83B | 12.27% |
| 2019-06-30 | $2.50B | $18.67B | 12.27% |
| 2019-03-31 | $3.59B | $21.48B | 17.13% |
| 2018-12-31 | $3.59B | $21.20B | 17.34% |
| 2018-09-30 | $3.51B | $20.22B | 17.48% |
| 2018-06-30 | $3.62B | $20.83B | 18.18% |
| 2018-03-31 | $2.59B | $20.54B | 13.35% |
| 2017-12-31 | $2.67B | $18.79B | 14.02% |
| 2017-09-30 | $2.84B | $19.40B | 14.92% |
| 2017-06-30 | $2.79B | $18.79B | 14.87% |
| 2017-03-31 | $2.79B | $19.22B | 14.92% |
| 2016-12-31 | $2.64B | $18.66B | 14.20% |
| 2016-09-30 | $2.51B | $18.41B | 13.59% |
| 2016-06-30 | $2.46B | $18.53B | 13.26% |
| 2016-03-31 | $2.36B | $18.66B | 12.63% |
| 2015-12-31 | $2.33B | $18.35B | 12.39% |
| 2015-09-30 | $2.33B | $18.59B | 12.28% |
| 2015-06-30 | $2.30B | $19.23B | 12.21% |
| 2015-03-31 | $2.31B | $18.98B | 12.33% |
| 2014-12-31 | $2.25B | $19.04B | 12.12% |
| 2014-09-30 | $2.25B | $18.24B | 12.29% |
| 2014-06-30 | $2.21B | $18.77B | 12.20% |
| 2014-03-31 | $2.19B | $18.33B | 12.32% |
| 2013-12-31 | $2.23B | $17.88B | 12.75% |
| 2013-09-30 | $2.12B | $17.51B | 12.20% |
| 2013-06-30 | $2.14B | $17.31B | 12.32% |
| 2013-03-31 | $2.16B | $17.26B | 13.00% |
| 2012-12-31 | $2.16B | $17.57B | 13.52% |
| 2012-09-30 | $2.19B | $17.17B | 14.49% |
| 2012-06-30 | $2.15B | $14.56B | 15.13% |
| 2012-03-31 | $2.10B | $14.72B | 14.81% |
| 2011-12-31 | $2.05B | $13.97B | 19.54% |
| 2011-09-30 | $2.01B | $13.70B | 20.09% |
| 2011-06-30 | $1.97B | $14.19B | 20.74% |
| 2011-03-31 | $1.94B | 22.96% | |
| 2010-12-31 | $1.92B | $12.11B | 17.52% |
| 2010-09-30 | $1.87B | $11.78B | 17.31% |
| 2010-06-30 | $1.83B | $9.88B | 17.12% |
| 2010-03-31 | $1.78B | $10.16B | 16.33% |
| 2009-12-31 | $1.76B | $11.46B | 16.06% |
| 2009-09-30 | $1.70B | $11.28B | 16.09% |
| 2009-06-30 | $1.67B | $10.81B | 16.36% |
| 2009-03-31 | $1.68B | $10.20B | 16.79% |
| 2008-12-31 | $1.67B | $9.92B | 16.82% |
| 2008-09-30 | $1.67B | $9.88B | 16.91% |
| 2008-06-30 | $1.64B | $10.01B | 16.88% |
| 2008-03-31 | $1.60B | $9.97B | 17.00% |
| 2007-12-31 | $1.58B | $9.58B | 17.28% |
| 2007-09-30 | $1.51B | $9.36B | 16.88% |
| 2007-06-30 | $1.46B | $8.84B | 16.72% |
| 2007-03-31 | $1.40B | $8.80B | 16.20% |
| 2006-12-31 | $1.28B | $8.70B | 19.90% |
| 2006-09-30 | $1.17B | $8.53B | 21.58% |
| 2006-06-30 | $1.06B | $8.52B | 22.35% |
| 2006-03-31 | $0.96B | 24.36% | |
| 2005-12-31 | $0.94B | $4.68B | 17.57% |
| 2005-09-30 | $0.92B | $5.79B | 16.65% |
| 2005-06-30 | $0.90B | $5.32B | 16.46% |
| 2005-03-31 | $0.87B | $5.49B | 15.94% |
| 2004-12-31 | $0.85B | $5.46B | 15.46% |
| 2004-09-30 | $0.99B | $5.49B | 17.80% |
| 2004-06-30 | $0.91B | $5.48B | 18.31% |
| 2004-03-31 | $0.83B | $5.60B | 18.67% |
| 2003-12-31 | $0.76B | $5.60B | 20.69% |
| 2003-09-30 | $0.91B | $3.19B | 29.86% |
| 2003-06-30 | $0.88B | $3.38B | 29.27% |
| 2003-03-31 | $0.88B | $2.48B | 30.25% |
| 2002-12-31 | $0.88B | $3.11B | 27.45% |
| 2002-09-30 | $0.69B | $3.09B | 20.79% |
| 2002-06-30 | $1.01B | $2.94B | 28.89% |
| 2002-03-31 | $0.99B | $3.61B | 27.04% |
| 2001-12-31 | $1.32B | $3.60B | 37.20% |
| 2001-09-30 | $1.39B | $3.81B | 39.82% |
| 2001-06-30 | $1.36B | $3.62B | 43.24% |
| 2001-03-31 | $1.35B | $3.14B | 47.45% |
| 2000-12-31 | $1.26B | $3.41B | 44.32% |
| 2000-09-30 | $0.96B | $2.37B | 35.20% |
| 2000-06-30 | $0.93B | $2.48B | 31.72% |
| 2000-03-31 | $1.17B | $3.08B | 36.47% |
| 1999-12-31 | $1.14B | $3.03B | 36.12% |
| 1999-09-30 | $1.46B | $3.10B | 42.98% |
| 1999-06-30 | $1.19B | $3.59B | 32.78% |
| 1999-03-31 | $1.16B | $2.95B | 30.83% |
| 1998-12-31 | $1.04B | $3.92B | 25.42% |
| 1998-09-30 | $0.63B | $4.01B | 15.66% |
| 1998-06-30 | $0.56B | $4.13B | 16.64% |
| 1998-03-31 | $0.48B | $4.22B | 15.08% |
| 1997-12-31 | $0.48B | $3.59B | 15.27% |
| 1997-09-30 | $0.71B | $1.54B | 26.69% |
| 1997-06-30 | $1.49B | $3.49B | 47.35% |
| 1997-03-31 | $1.35B | $3.88B | 46.70% |
| 1996-12-31 | $1.09B | $1.71B | 42.26% |
| 1996-09-30 | $1.16B | $3.49B | 41.51% |
| 1996-06-30 | $0.73B | $2.53B | 27.71% |
| 1996-03-31 | $0.81B | $2.60B | 29.44% |
| 1995-12-31 | $1.42B | $2.53B | 50.38% |
| 1995-09-30 | $1.79B | $2.95B | 63.04% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $20.627B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.567B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $189.075B | 73.97 |
| IDEXX Laboratories (IDXX) | United States | $54.780B | 54.40 |
| Edwards Lifesciences (EW) | United States | $48.432B | 32.47 |
| IQVIA Holdings (IQV) | United States | $39.797B | 22.19 |
| Alcon (ALC) | Switzerland | $39.104B | 26.35 |
| Mettler-Toledo (MTD) | United States | $28.673B | 33.55 |
| DexCom (DXCM) | United States | $27.586B | 38.03 |
| STERIS (STE) | Ireland | $25.321B | 26.14 |
| Waters (WAT) | United States | $22.858B | 30.23 |
| Coloplast (CLPBY) | Denmark | $18.998B | 32.42 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.345B | 0.00 |
| Penumbra (PEN) | United States | $13.920B | 97.92 |
| Globus Medical (GMED) | United States | $12.440B | 26.11 |
| Masimo (MASI) | United States | $7.665B | 24.56 |
| Glaukos (GKOS) | United States | $7.090B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.188B | 19.66 |
| TransMedics (TMDX) | United States | $4.850B | 57.46 |
| Teleflex (TFX) | United States | $4.434B | 7.07 |
| LivaNova (LIVN) | United Kingdom | $3.436B | 18.56 |
| Veracyte (VCYT) | United States | $3.296B | 37.56 |
| Integer Holdings (ITGR) | United States | $2.984B | 14.01 |
| Alphatec Holdings (ATEC) | United States | $2.548B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.400B | 22.45 |
| Artivion (AORT) | United States | $2.061B | 94.59 |
| UFP Technologies (UFPT) | United States | $2.023B | 26.71 |
| Nihon Kohden (NHNKY) | Japan | $1.955B | 17.07 |
| PROCEPT BioRobotics (PRCT) | United States | $1.694B | 0.00 |
| AxoGen (AXGN) | United States | $1.470B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.389B | 0.00 |
| IRadimed (IRMD) | United States | $1.310B | 62.41 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.937B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.935B | 5.07 |
| Beta Bionics (BBNX) | United States | $0.811B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.671B | 38.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.550B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.548B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.540B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.463B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.458B | 12.63 |
| AngioDynamics (ANGO) | United States | $0.427B | 0.00 |
| RxSight (RXST) | United States | $0.397B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.360B | 59.94 |
| Sight Sciences (SGHT) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.237B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.195B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.143B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Neuronetics (STIM) | United States | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.126B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| Positron (POSC) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Venus Concept (VERO) | Canada | $0.006B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |